MedTrace Logo

Intravenous Iron in Patients With Anemia of Chronic Kidney Disease

NCT00204256 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2005-09-20

No results posted yet for this study

Summary

The objective of this study is the evaluation of the efficacy and safety of intravenous iron sucrose in anemic patients with chronic kidney disease not on renal replacement therapy.

Conditions

  • Kidney Failure, Chronic

Interventions

DRUG

Iron sucrose

Sponsors & Collaborators

  • University Hospital Muenster

    lead OTHER

Principal Investigators

  • Roland M Schaefer, MD · University Hospital Muenster

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-03-31
Completion
2005-03-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00204256 on ClinicalTrials.gov